| Literature DB >> 26481084 |
Altayyeb Yousef1, Michael Froeschl1, Benjamin Hibbert1, Ian G Burwash1, Marino Labinaz2.
Abstract
Transcatheter Aortic Valve Implantation (TAVI) was initially developed to treat aortic stenosis in patients with high risk for surgical intervention. With great initial adoption of the technology and improvements in device design and procedural success TAVI is increasingly being performed in broader populations for diverse indications. This paper is a concise review of the evolving and expanding use of TAVI in the current era.Entities:
Mesh:
Year: 2015 PMID: 26481084 DOI: 10.1016/j.cjca.2015.04.033
Source DB: PubMed Journal: Can J Cardiol ISSN: 0828-282X Impact factor: 5.223